{"id":7115,"date":"2022-09-29T15:54:11","date_gmt":"2022-09-29T13:54:11","guid":{"rendered":"https:\/\/www.weinbergcapital.com\/?post_type=invests&#038;p=7115"},"modified":"2025-09-11T09:37:17","modified_gmt":"2025-09-11T07:37:17","slug":"pharma-omnium","status":"publish","type":"invests","link":"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/","title":{"rendered":"Pharma Omnium"},"content":{"rendered":"\n<h2 class=\"has-text-align-center wp-block-heading\">Company overview<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Pharma Omnium is a laboratory specializing in mature, well-known pharmaceutical products that are no longer heavily marketed but still have strong potential. The company thus meets a need expressed by government authorities, who wish to encourage prescriptions for less expensive drugs that retain their full therapeutic value among other approved medicines. Pharma Omnium\u2019s portfolio includes six reference medicinal products. Its production and distribution activities are subcontracted to external partners. The company also operates a laboratory engaged in pharmaceutical research on treatments for infectious diseases, with a virology division and a bacteriology division.<\/p>\n\n\n\n<h2 class=\"has-text-align-center wp-block-heading\">Our approach<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Weinberg Capital Partners assisted with the company\u2019s acquisitions programme and the development of its research activities, supported in particular by the high profitability of its portfolio of mature products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With our backing, the company made significant advances in laboratory research, particularly in bacteriology, with several of its projects selected for inclusion in research programmes across Europe and North America, or pursued jointly with major international pharmaceutical groups providing human resources as well as financial support, leading to validation and recognition for Pharma Omnium within the scientific community.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Company overview Pharma Omnium is a laboratory specializing in mature, well-known pharmaceutical products that are no longer heavily marketed but still have strong potential. The company thus meets a need expressed by government authorities, who wish to encourage prescriptions for less expensive drugs that retain their full therapeutic value among other approved medicines. Pharma Omnium\u2019s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-7115","invests","type-invests","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharma Omnium - Weinberg Capital Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Omnium - Weinberg Capital Partners\" \/>\n<meta property=\"og:description\" content=\"Company overview Pharma Omnium is a laboratory specializing in mature, well-known pharmaceutical products that are no longer heavily marketed but still have strong potential. The company thus meets a need expressed by government authorities, who wish to encourage prescriptions for less expensive drugs that retain their full therapeutic value among other approved medicines. Pharma Omnium\u2019s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/\" \/>\n<meta property=\"og:site_name\" content=\"Weinberg Capital Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-11T07:37:17+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.weinbergcapital.com\\\/en\\\/invest\\\/pharma-omnium\\\/\",\"url\":\"https:\\\/\\\/www.weinbergcapital.com\\\/en\\\/invest\\\/pharma-omnium\\\/\",\"name\":\"Pharma Omnium - Weinberg Capital Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.weinbergcapital.com\\\/#website\"},\"datePublished\":\"2022-09-29T13:54:11+00:00\",\"dateModified\":\"2025-09-11T07:37:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.weinbergcapital.com\\\/en\\\/invest\\\/pharma-omnium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.weinbergcapital.com\\\/en\\\/invest\\\/pharma-omnium\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.weinbergcapital.com\\\/en\\\/invest\\\/pharma-omnium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.weinbergcapital.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investissements\",\"item\":\"https:\\\/\\\/www.weinbergcapital.com\\\/investissement\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pharma Omnium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.weinbergcapital.com\\\/#website\",\"url\":\"https:\\\/\\\/www.weinbergcapital.com\\\/\",\"name\":\"Weinberg Capital Partners\",\"description\":\"Une approche flexible et partenariale pour aider les dirigeants \u00e0 recomposer leur capital\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.weinbergcapital.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma Omnium - Weinberg Capital Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/","og_locale":"en_US","og_type":"article","og_title":"Pharma Omnium - Weinberg Capital Partners","og_description":"Company overview Pharma Omnium is a laboratory specializing in mature, well-known pharmaceutical products that are no longer heavily marketed but still have strong potential. The company thus meets a need expressed by government authorities, who wish to encourage prescriptions for less expensive drugs that retain their full therapeutic value among other approved medicines. Pharma Omnium\u2019s [&hellip;]","og_url":"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/","og_site_name":"Weinberg Capital Partners","article_modified_time":"2025-09-11T07:37:17+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/","url":"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/","name":"Pharma Omnium - Weinberg Capital Partners","isPartOf":{"@id":"https:\/\/www.weinbergcapital.com\/#website"},"datePublished":"2022-09-29T13:54:11+00:00","dateModified":"2025-09-11T07:37:17+00:00","breadcrumb":{"@id":"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.weinbergcapital.com\/en\/invest\/pharma-omnium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.weinbergcapital.com\/en\/"},{"@type":"ListItem","position":2,"name":"Investissements","item":"https:\/\/www.weinbergcapital.com\/investissement\/"},{"@type":"ListItem","position":3,"name":"Pharma Omnium"}]},{"@type":"WebSite","@id":"https:\/\/www.weinbergcapital.com\/#website","url":"https:\/\/www.weinbergcapital.com\/","name":"Weinberg Capital Partners","description":"Une approche flexible et partenariale pour aider les dirigeants \u00e0 recomposer leur capital","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.weinbergcapital.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.weinbergcapital.com\/en\/wp-json\/wp\/v2\/invests\/7115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.weinbergcapital.com\/en\/wp-json\/wp\/v2\/invests"}],"about":[{"href":"https:\/\/www.weinbergcapital.com\/en\/wp-json\/wp\/v2\/types\/invests"}],"author":[{"embeddable":true,"href":"https:\/\/www.weinbergcapital.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.weinbergcapital.com\/en\/wp-json\/wp\/v2\/comments?post=7115"}],"version-history":[{"count":6,"href":"https:\/\/www.weinbergcapital.com\/en\/wp-json\/wp\/v2\/invests\/7115\/revisions"}],"predecessor-version":[{"id":22226,"href":"https:\/\/www.weinbergcapital.com\/en\/wp-json\/wp\/v2\/invests\/7115\/revisions\/22226"}],"wp:attachment":[{"href":"https:\/\/www.weinbergcapital.com\/en\/wp-json\/wp\/v2\/media?parent=7115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}